The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Eluting Beads Market Research Report 2025
Synopsis
Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
The global Drug Eluting Beads market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Beads, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Beads.
Report Scope
The Drug Eluting Beads market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Eluting Beads market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Beads manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocompatibles
BTG International
Merit Medical Systems
CeloNova BioSciences
ABK Biomedical
Boston Scientific
Medtronic
Merit Medical Systems
Surefire Medical
Terumo
Segment by Type
Oncozene Beads
Quadra Sphere
LC Beads
Others
Segment by Application
Hospitals
Specialized Clinics
Research Centers
Ambulatory Surgical Centers
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Beads manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Beads in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
The global Drug Eluting Beads market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Beads, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Beads.
Report Scope
The Drug Eluting Beads market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Eluting Beads market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Beads manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocompatibles
BTG International
Merit Medical Systems
CeloNova BioSciences
ABK Biomedical
Boston Scientific
Medtronic
Merit Medical Systems
Surefire Medical
Terumo
Segment by Type
Oncozene Beads
Quadra Sphere
LC Beads
Others
Segment by Application
Hospitals
Specialized Clinics
Research Centers
Ambulatory Surgical Centers
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Beads manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Beads in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Drug Eluting Beads Market Overview
1.1 Product Overview and Scope of Drug Eluting Beads
1.2 Drug Eluting Beads Segment by Type
1.2.1 Global Drug Eluting Beads Market Value Comparison by Type (2024-2030)
1.2.2 Oncozene Beads
1.2.3 Quadra Sphere
1.2.4 LC Beads
1.2.5 Others
1.3 Drug Eluting Beads Segment by Application
1.3.1 Global Drug Eluting Beads Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Research Centers
1.3.5 Ambulatory Surgical Centers
1.4 Global Drug Eluting Beads Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Beads Revenue 2019-2030
1.4.2 Global Drug Eluting Beads Sales 2019-2030
1.4.3 Global Drug Eluting Beads Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug Eluting Beads Market Competition by Manufacturers
2.1 Global Drug Eluting Beads Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug Eluting Beads Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug Eluting Beads Average Price by Manufacturers (2019-2024)
2.4 Global Drug Eluting Beads Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Eluting Beads, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Beads, Product Type & Application
2.7 Drug Eluting Beads Market Competitive Situation and Trends
2.7.1 Drug Eluting Beads Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug Eluting Beads Players Market Share by Revenue
2.7.3 Global Drug Eluting Beads Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Eluting Beads Retrospective Market Scenario by Region
3.1 Global Drug Eluting Beads Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug Eluting Beads Global Drug Eluting Beads Sales by Region: 2019-2030
3.2.1 Global Drug Eluting Beads Sales by Region: 2019-2024
3.2.2 Global Drug Eluting Beads Sales by Region: 2025-2030
3.3 Global Drug Eluting Beads Global Drug Eluting Beads Revenue by Region: 2019-2030
3.3.1 Global Drug Eluting Beads Revenue by Region: 2019-2024
3.3.2 Global Drug Eluting Beads Revenue by Region: 2025-2030
3.4 North America Drug Eluting Beads Market Facts & Figures by Country
3.4.1 North America Drug Eluting Beads Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug Eluting Beads Sales by Country (2019-2030)
3.4.3 North America Drug Eluting Beads Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug Eluting Beads Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Beads Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug Eluting Beads Sales by Country (2019-2030)
3.5.3 Europe Drug Eluting Beads Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Beads Market Facts & Figures by Country
3.6.1 Asia Pacific Drug Eluting Beads Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug Eluting Beads Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug Eluting Beads Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drug Eluting Beads Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Beads Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug Eluting Beads Sales by Country (2019-2030)
3.7.3 Latin America Drug Eluting Beads Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Beads Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Beads Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug Eluting Beads Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug Eluting Beads Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Drug Eluting Beads Sales by Type (2019-2030)
4.1.1 Global Drug Eluting Beads Sales by Type (2019-2024)
4.1.2 Global Drug Eluting Beads Sales by Type (2025-2030)
4.1.3 Global Drug Eluting Beads Sales Market Share by Type (2019-2030)
4.2 Global Drug Eluting Beads Revenue by Type (2019-2030)
4.2.1 Global Drug Eluting Beads Revenue by Type (2019-2024)
4.2.2 Global Drug Eluting Beads Revenue by Type (2025-2030)
4.2.3 Global Drug Eluting Beads Revenue Market Share by Type (2019-2030)
4.3 Global Drug Eluting Beads Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug Eluting Beads Sales by Application (2019-2030)
5.1.1 Global Drug Eluting Beads Sales by Application (2019-2024)
5.1.2 Global Drug Eluting Beads Sales by Application (2025-2030)
5.1.3 Global Drug Eluting Beads Sales Market Share by Application (2019-2030)
5.2 Global Drug Eluting Beads Revenue by Application (2019-2030)
5.2.1 Global Drug Eluting Beads Revenue by Application (2019-2024)
5.2.2 Global Drug Eluting Beads Revenue by Application (2025-2030)
5.2.3 Global Drug Eluting Beads Revenue Market Share by Application (2019-2030)
5.3 Global Drug Eluting Beads Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Biocompatibles
6.1.1 Biocompatibles Corporation Information
6.1.2 Biocompatibles Description and Business Overview
6.1.3 Biocompatibles Drug Eluting Beads Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Biocompatibles Drug Eluting Beads Product Portfolio
6.1.5 Biocompatibles Recent Developments/Updates
6.2 BTG International
6.2.1 BTG International Corporation Information
6.2.2 BTG International Description and Business Overview
6.2.3 BTG International Drug Eluting Beads Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BTG International Drug Eluting Beads Product Portfolio
6.2.5 BTG International Recent Developments/Updates
6.3 Merit Medical Systems
6.3.1 Merit Medical Systems Corporation Information
6.3.2 Merit Medical Systems Description and Business Overview
6.3.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merit Medical Systems Drug Eluting Beads Product Portfolio
6.3.5 Merit Medical Systems Recent Developments/Updates
6.4 CeloNova BioSciences
6.4.1 CeloNova BioSciences Corporation Information
6.4.2 CeloNova BioSciences Description and Business Overview
6.4.3 CeloNova BioSciences Drug Eluting Beads Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CeloNova BioSciences Drug Eluting Beads Product Portfolio
6.4.5 CeloNova BioSciences Recent Developments/Updates
6.5 ABK Biomedical
6.5.1 ABK Biomedical Corporation Information
6.5.2 ABK Biomedical Description and Business Overview
6.5.3 ABK Biomedical Drug Eluting Beads Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ABK Biomedical Drug Eluting Beads Product Portfolio
6.5.5 ABK Biomedical Recent Developments/Updates
6.6 Boston Scientific
6.6.1 Boston Scientific Corporation Information
6.6.2 Boston Scientific Description and Business Overview
6.6.3 Boston Scientific Drug Eluting Beads Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boston Scientific Drug Eluting Beads Product Portfolio
6.6.5 Boston Scientific Recent Developments/Updates
6.7 Medtronic
6.6.1 Medtronic Corporation Information
6.6.2 Medtronic Description and Business Overview
6.6.3 Medtronic Drug Eluting Beads Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medtronic Drug Eluting Beads Product Portfolio
6.7.5 Medtronic Recent Developments/Updates
6.8 Merit Medical Systems
6.8.1 Merit Medical Systems Corporation Information
6.8.2 Merit Medical Systems Description and Business Overview
6.8.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merit Medical Systems Drug Eluting Beads Product Portfolio
6.8.5 Merit Medical Systems Recent Developments/Updates
6.9 Surefire Medical
6.9.1 Surefire Medical Corporation Information
6.9.2 Surefire Medical Description and Business Overview
6.9.3 Surefire Medical Drug Eluting Beads Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Surefire Medical Drug Eluting Beads Product Portfolio
6.9.5 Surefire Medical Recent Developments/Updates
6.10 Terumo
6.10.1 Terumo Corporation Information
6.10.2 Terumo Description and Business Overview
6.10.3 Terumo Drug Eluting Beads Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Terumo Drug Eluting Beads Product Portfolio
6.10.5 Terumo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Beads Industry Chain Analysis
7.2 Drug Eluting Beads Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Beads Production Mode & Process
7.4 Drug Eluting Beads Sales and Marketing
7.4.1 Drug Eluting Beads Sales Channels
7.4.2 Drug Eluting Beads Distributors
7.5 Drug Eluting Beads Customers
8 Drug Eluting Beads Market Dynamics
8.1 Drug Eluting Beads Industry Trends
8.2 Drug Eluting Beads Market Drivers
8.3 Drug Eluting Beads Market Challenges
8.4 Drug Eluting Beads Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Drug Eluting Beads Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Drug Eluting Beads Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Drug Eluting Beads Market Competitive Situation by Manufacturers in 2023
Table 4. Global Drug Eluting Beads Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Drug Eluting Beads Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Drug Eluting Beads Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Drug Eluting Beads Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Drug Eluting Beads Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Drug Eluting Beads, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drug Eluting Beads, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drug Eluting Beads, Product Type & Application
Table 12. Global Key Manufacturers of Drug Eluting Beads, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Eluting Beads by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Beads as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Eluting Beads Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Drug Eluting Beads Sales by Region (2019-2024) & (K Units)
Table 18. Global Drug Eluting Beads Sales Market Share by Region (2019-2024)
Table 19. Global Drug Eluting Beads Sales by Region (2025-2030) & (K Units)
Table 20. Global Drug Eluting Beads Sales Market Share by Region (2025-2030)
Table 21. Global Drug Eluting Beads Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Drug Eluting Beads Revenue Market Share by Region (2019-2024)
Table 23. Global Drug Eluting Beads Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Drug Eluting Beads Revenue Market Share by Region (2025-2030)
Table 25. North America Drug Eluting Beads Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Drug Eluting Beads Sales by Country (2019-2024) & (K Units)
Table 27. North America Drug Eluting Beads Sales by Country (2025-2030) & (K Units)
Table 28. North America Drug Eluting Beads Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Drug Eluting Beads Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Drug Eluting Beads Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Drug Eluting Beads Sales by Country (2019-2024) & (K Units)
Table 32. Europe Drug Eluting Beads Sales by Country (2025-2030) & (K Units)
Table 33. Europe Drug Eluting Beads Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Drug Eluting Beads Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Drug Eluting Beads Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Drug Eluting Beads Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Drug Eluting Beads Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Drug Eluting Beads Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Drug Eluting Beads Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Drug Eluting Beads Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Drug Eluting Beads Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Drug Eluting Beads Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Drug Eluting Beads Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Drug Eluting Beads Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Drug Eluting Beads Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Drug Eluting Beads Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Drug Eluting Beads Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Drug Eluting Beads Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Drug Eluting Beads Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Drug Eluting Beads Sales (K Units) by Type (2019-2024)
Table 51. Global Drug Eluting Beads Sales (K Units) by Type (2025-2030)
Table 52. Global Drug Eluting Beads Sales Market Share by Type (2019-2024)
Table 53. Global Drug Eluting Beads Sales Market Share by Type (2025-2030)
Table 54. Global Drug Eluting Beads Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Drug Eluting Beads Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Drug Eluting Beads Revenue Market Share by Type (2019-2024)
Table 57. Global Drug Eluting Beads Revenue Market Share by Type (2025-2030)
Table 58. Global Drug Eluting Beads Price (USD/Unit) by Type (2019-2024)
Table 59. Global Drug Eluting Beads Price (USD/Unit) by Type (2025-2030)
Table 60. Global Drug Eluting Beads Sales (K Units) by Application (2019-2024)
Table 61. Global Drug Eluting Beads Sales (K Units) by Application (2025-2030)
Table 62. Global Drug Eluting Beads Sales Market Share by Application (2019-2024)
Table 63. Global Drug Eluting Beads Sales Market Share by Application (2025-2030)
Table 64. Global Drug Eluting Beads Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Drug Eluting Beads Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Drug Eluting Beads Revenue Market Share by Application (2019-2024)
Table 67. Global Drug Eluting Beads Revenue Market Share by Application (2025-2030)
Table 68. Global Drug Eluting Beads Price (USD/Unit) by Application (2019-2024)
Table 69. Global Drug Eluting Beads Price (USD/Unit) by Application (2025-2030)
Table 70. Biocompatibles Corporation Information
Table 71. Biocompatibles Description and Business Overview
Table 72. Biocompatibles Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Biocompatibles Drug Eluting Beads Product
Table 74. Biocompatibles Recent Developments/Updates
Table 75. BTG International Corporation Information
Table 76. BTG International Description and Business Overview
Table 77. BTG International Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. BTG International Drug Eluting Beads Product
Table 79. BTG International Recent Developments/Updates
Table 80. Merit Medical Systems Corporation Information
Table 81. Merit Medical Systems Description and Business Overview
Table 82. Merit Medical Systems Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Merit Medical Systems Drug Eluting Beads Product
Table 84. Merit Medical Systems Recent Developments/Updates
Table 85. CeloNova BioSciences Corporation Information
Table 86. CeloNova BioSciences Description and Business Overview
Table 87. CeloNova BioSciences Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. CeloNova BioSciences Drug Eluting Beads Product
Table 89. CeloNova BioSciences Recent Developments/Updates
Table 90. ABK Biomedical Corporation Information
Table 91. ABK Biomedical Description and Business Overview
Table 92. ABK Biomedical Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. ABK Biomedical Drug Eluting Beads Product
Table 94. ABK Biomedical Recent Developments/Updates
Table 95. Boston Scientific Corporation Information
Table 96. Boston Scientific Description and Business Overview
Table 97. Boston Scientific Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Boston Scientific Drug Eluting Beads Product
Table 99. Boston Scientific Recent Developments/Updates
Table 100. Medtronic Corporation Information
Table 101. Medtronic Description and Business Overview
Table 102. Medtronic Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Medtronic Drug Eluting Beads Product
Table 104. Medtronic Recent Developments/Updates
Table 105. Merit Medical Systems Corporation Information
Table 106. Merit Medical Systems Description and Business Overview
Table 107. Merit Medical Systems Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Merit Medical Systems Drug Eluting Beads Product
Table 109. Merit Medical Systems Recent Developments/Updates
Table 110. Surefire Medical Corporation Information
Table 111. Surefire Medical Description and Business Overview
Table 112. Surefire Medical Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Surefire Medical Drug Eluting Beads Product
Table 114. Surefire Medical Recent Developments/Updates
Table 115. Terumo Corporation Information
Table 116. Terumo Description and Business Overview
Table 117. Terumo Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Terumo Drug Eluting Beads Product
Table 119. Terumo Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Drug Eluting Beads Distributors List
Table 123. Drug Eluting Beads Customers List
Table 124. Drug Eluting Beads Market Trends
Table 125. Drug Eluting Beads Market Drivers
Table 126. Drug Eluting Beads Market Challenges
Table 127. Drug Eluting Beads Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug Eluting Beads
Figure 2. Global Drug Eluting Beads Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Drug Eluting Beads Market Share by Type in 2023 & 2030
Figure 4. Oncozene Beads Product Picture
Figure 5. Quadra Sphere Product Picture
Figure 6. LC Beads Product Picture
Figure 7. Others Product Picture
Figure 8. Global Drug Eluting Beads Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Drug Eluting Beads Market Share by Application in 2023 & 2030
Figure 10. Hospitals
Figure 11. Specialized Clinics
Figure 12. Research Centers
Figure 13. Ambulatory Surgical Centers
Figure 14. Global Drug Eluting Beads Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Drug Eluting Beads Market Size (2019-2030) & (US$ Million)
Figure 16. Global Drug Eluting Beads Sales (2019-2030) & (K Units)
Figure 17. Global Drug Eluting Beads Average Price (USD/Unit) & (2019-2030)
Figure 18. Drug Eluting Beads Report Years Considered
Figure 19. Drug Eluting Beads Sales Share by Manufacturers in 2023
Figure 20. Global Drug Eluting Beads Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Drug Eluting Beads Players: Market Share by Revenue in 2023
Figure 22. Drug Eluting Beads Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Drug Eluting Beads Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Drug Eluting Beads Sales Market Share by Country (2019-2030)
Figure 25. North America Drug Eluting Beads Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Drug Eluting Beads Sales Market Share by Country (2019-2030)
Figure 29. Europe Drug Eluting Beads Revenue Market Share by Country (2019-2030)
Figure 30. Germany Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Drug Eluting Beads Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Drug Eluting Beads Revenue Market Share by Region (2019-2030)
Figure 37. China Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Drug Eluting Beads Sales Market Share by Country (2019-2030)
Figure 48. Latin America Drug Eluting Beads Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Drug Eluting Beads Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Drug Eluting Beads Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Drug Eluting Beads Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Drug Eluting Beads by Type (2019-2030)
Figure 58. Global Revenue Market Share of Drug Eluting Beads by Type (2019-2030)
Figure 59. Global Drug Eluting Beads Price (USD/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Drug Eluting Beads by Application (2019-2030)
Figure 61. Global Revenue Market Share of Drug Eluting Beads by Application (2019-2030)
Figure 62. Global Drug Eluting Beads Price (USD/Unit) by Application (2019-2030)
Figure 63. Drug Eluting Beads Value Chain
Figure 64. Drug Eluting Beads Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
